Related Articles
Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Efficacy of chemotherapy plus gefitinib treatment in advanced non‑small‑cell lung cancer patients following acquired resistance to gefitinib
A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma
Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study
Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type